-+ 0.00%
-+ 0.00%
-+ 0.00%

AMBROS THERAPEUTICS ANNOUNCES PLANNED INTERIM ANALYSIS OF PHASE 3 CLINICAL TRIAL FOLLOWING FDA FEEDBACK

路透·10/26/2026 12:35:19

請登錄查看新聞詳情